Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07645131 · ClinicalTrials.gov registry record · NA

Development of a Mobile Health Intervention to Support Functioning of Veterans With Substance Use Disorders

A NA study, sponsored by VA Office of Research and Development.

Not yet
Registry status
NA
Development phase
30
Enrollment target

NCT07645131: Clinical Trial NA study, sponsored by VA Office of Research and Development.

NCT07645131 is a NA study that has not yet begun recruiting, run by VA Office of Research and Development. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT07645131, a NA study, has not yet begun recruiting, sponsored by VA Office of Research and Development.

NOT YET RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

This project will involve the development, refinement, and preliminary testing of a mobile health intervention (Motivational Enhancement Therapy Skills for Veterans; "METS4Vets"), which will be delivered through a smartphone app. The intervention will aim to support Veterans who are navigating the critical transition from structured residential substance use treatment to outpatient settings.

Primary Outcome

The Systems Usability Scale (SUS) will be used to assess the perceived usability of the intervention. The SUS is a 10-item Likert-type self-report measure that generates a subjective score to assess whether the system is sufficiently usable in its current form. Responses range from 0 to 4 with a total score ranging from 0 - 100. A score above 68 is considered above average while scores above 80 are considered highly favorable and indicative of recommending the product to friends.

Interventions

  • BEHAVIORAL METS4Vets

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2026-10-01
Est. Completion 2031-09-30
Phase NA
VA Office of Research and Development

1,668 total trials

What is known before NCT07645131 opens enrollment

NCT07645131 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which METS4Vets is the first listed.

NCT07645131 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07645131 about?

NCT07645131 is a clinical study titled "Development of a Mobile Health Intervention to Support Functioning of Veterans With Substance Use Disorders". This project will involve the development, refinement, and preliminary testing of a mobile health intervention (Motivational Enhancement Therapy Skills for Veterans; "METS4Vets"), which will be delivered through a smartphone app. The intervention will aim to support Veterans who are navigating the c...

What is the current status of trial NCT07645131?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-10-01. Estimated completion is 2031-09-30.

What interventions are being tested in trial NCT07645131?

The interventions under investigation include: METS4Vets (BEHAVIORAL).

Who is sponsoring clinical trial NCT07645131?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07645131's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07645131, the US trial registry maintained by the National Library of Medicine. NCT07645131 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.